Page last updated: 2024-10-30

lansoprazole and Adenomatous Polyps

lansoprazole has been researched along with Adenomatous Polyps in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Adenomatous Polyps: Benign neoplasms derived from glandular epithelium. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nam, SY1
Lee, SW1
Jeon, SW1
Kwon, YH1
Lee, HS1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp (Randomized Controlled Study)[NCT03065868]Phase 432 participants (Actual)Interventional2015-12-09Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for lansoprazole and Adenomatous Polyps

ArticleYear
Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial.
    Digestive diseases and sciences, 2020, Volume: 65, Issue:12

    Topics: Adenomatous Polyps; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Monitorin

2020